1 Executive summary
2 Introduction & methodology
3 Overview of pyrethroids industry in China
3.1 Definition and classification of pyrethroids
3.2 Development history of pyrethroids industry in China
3.3 Position of pyrethroids in the global insecticide industry
3.4 Position of pyrethroids in Chinese insecticide industry
3.5 Comprehensive economic benefit analysis (Industry scale, profit level)
4 Supply and demand of pyrethroids in China
4.1 Summary of supply and demand
4.1.1 Supply summary
4.1.1.1 - Production situation (capacity and output), 2008~2010
4.1.1.2 - Key manufacturers
4.1.1.3 - Output volume and value of key producers
4.1.1.4 - SWOT analysis of top 5 manufacturers
4.1.2 Demand summary
4.1.2.1 Consumption volume and value
4.1.2.2 Consumption structure
4.1.2.2.1 - Market share by application fields, 2010
4.1.2.2.2 - Market share by crops, 2010
4.1.2.2.3 - Market share by products, 2010
4.1.2.2.4 - Market share by regions, 2010
4.1.2.3 Consumption habit
4.2 Supply and demand of key products
4.2.1 Lambda-cyhalothrin
4.2.1.1 - Registration
4.2.1.2 - Production situation (capacity, output, key producers, etc.)
4.2.1.3 - Price
4.2.1.4 - Consumption (market volume and value, consumption structure, share of
key players, etc.)
4.2.2 Bifenthrin
4.2.2.1 - Registration
4.2.2.2 - Production situation (capacity, output, key producers, etc.)
4.2.2.3 - Price
4.2.2.4 - Consumption (market volume and value, consumption structure, share of
key players, etc.)
4.2.3 Alpha-cypermethrin
4.2.3.1 - Registration
4.2.3.2 - Production situation (capacity, output, key producers, etc.)
4.2.3.3 - Price
4.2.3.4 - Consumption (market volume and value, consumption structure, share of
key players, etc.)
4.2.4 Beta-cyfluthrin
4.2.4.1 - Registration
4.2.4.2 - Production situation (capacity, output, key producers, etc.)
4.2.4.3 - Price
4.2.4.4 - Consumption (market volume and value, consumption structure, share of
key players, etc.)
4.2.5 Deltamethrin
4.2.5.1 - Registration
4.2.5.2 - Production situation (capacity, output, key producers, etc.)
4.2.5.3 - Price
4.2.5.4 - Consumption (market volume and value, consumption structure, share of
key players, etc.)
4.2.6 Cypermethrin
4.2.6.1 - Registration
4.2.6.2 - Production situation (capacity, output, key producers, etc.)
4.2.6.3 - Price
4.2.6.4 - Consumption (market volume and value, consumption structure, share of
key players, etc.)
4.2.7 Fenpropathrin
4.2.7.1 - Registration
4.2.7.2 - Production situation (capacity, output, key producers, etc.)
4.2.7.3 - Price
4.2.7.4 - Consumption (market volume and value, consumption structure, share of
key players, etc.)
4.2.8 Fenvalerate
4.2.8.1 - Registration
4.2.8.2 - Production situation (capacity, output, key producers, etc.)
4.2.8.3 - Price
4.2.8.4 - Consumption (market volume and value, consumption structure, share of
key players, etc.)
4.2.9 Esfenvalerate
4.2.9.1 - Registration
4.2.9.2 - Production situation (capacity, output, key producers, etc.)
4.2.9.3 - Price
4.2.9.4 - Consumption (market volume and value, consumption structure, share of
key players, etc.)
4.2.10 Cyfluthrin
4.2.10.1 - Registration
4.2.10.2 - Production situation (capacity, output, key producers, etc.)
4.2.10.3 - Price
4.2.10.4 - Consumption (market volume and value, consumption structure, share of
key players, etc.)
4.2.11 Permethrin
4.2.11.1 - Registration
4.2.11.2 - Production situation (capacity, output, key producers, etc.)
4.2.11.3 - Price
4.2.11.4 - Consumption (market volume and value, consumption structure, share of
key players, etc.)
4.2.12 Beta-cypermethrin
4.2.12.1 - Registration
4.2.12.2 - Production situation (capacity, output, key producers, etc.)
4.2.12.3 - Price
4.2.12.4 - Consumption (market volume and value, consumption structure, share of
key players, etc.)
4.2.13 Others (including potential ones, especially non-crop pyrethroids)
5 Key factors influencing development of pyrethroids
5.1 Macro-economic environment ( GDP, peasants income level, industry scale,
etc.)
5.1.1 - GDP and per-capital GDP
5.1.2 - Peasants income level
5.1.3 - Industry scale
5.2 Governmental policies
5.3 Industry competition
5.3.1 - Industry concentration
5.3.2 - Industry competitiveness (Porters 5 Forces)
5.4 Distribution channels
5.5 Supply of raw material and intermediate
5.6 Production technlology
6 Forecast, 2011-2015
6.1 Supply forecast (capacity and output)
6.2 Demand forecast (market volume and value,consumption structure,etc.)
7 Risk assessment and market opportunities
8 Appendix: Profiles of major producers
LIST OF TABLE
Table 2-1 USD/RMB exchange rate, 2004-2011
Table 3.1-1 Classification of pyrethroids by chemical structure
Table 3.1-2 Classification of pyrethroids by photosensitivity
Table 3.4-1 Classification and major products of insecticide in China, 2011
Table 4.1.1.1-1 Production situation of key pyrethroids in China, as of May
2011, capacity: t/a, output: tonne
Table 4.1.1.2-1 Chinas top 9 pyrethroid producers and main products, 2010
Table 4.1.1.2-2 Production situation of Chinas top 9 pyrethroid producers, as
of May 2011, capacity: t/a, output: tonne
Table 4.1.1.3-1 Output volume and value of key pyrethroid producers in China,
2008-2010
Table 4.1.1.4-1 SWOT analysis of Nanjing Redsun Group Co., Ltd., 2011
Table 4.1.1.4-2 SWOT analysis of Jiangsu Yangnong Chemical Group Co., Ltd., 2011
Table 4.1.1.4-3 SWOT analysis of Jiangsu Huangma Agrochemicals Co., Ltd., 2011
Table 4.1.1.4-4 SWOT analysis of Shandong Dacheng Pesticide Co., Ltd., 2011
Table 4.1.1.4-5 SWOT analysis of Changzhou Kangmei Chemical Co., Ltd., 2011
Table 4.1.2.1-1 Consumption situation of pyrethroids calculated by AI in China,
volume(tonne) and share, 2008-2010
Table 4.1.2.2.3-1 Market volume and value of pyrethroids by products in China,
2008-2010, tonne, 000 USD
Table 4.2.1.1-1 Regional distribution of lambda-cyhalothrin technical
registrations in China, by May 2011
Table 4.2.1.1-2 Registration situation of single formulations of lambda-cyhalothrin
in China, by May 2011
Table 4.2.1.1-3 Registration situation of mixed formulations of lambda-cyhalothrin
in China, by May 2011
Table 4.2.1.2-1 Basic information of lambda-cyhalothrin technical producers in
China, as of May 2011
Table 4.2.1.2-2 Capacity and output of lambda-cyhalothrin technical producers in
China, as of May 2011
Table 4.2.1.2-3 Capacity situation of active producers of lambda-cyhalothrin
technical in China, t/a, as of May 2011
Table 4.2.1.4-1 Apparent consumption of lambda-cyhalothrin in China, converted
to 100% AI, tonne, 2008-2010
Table 4.2.1.4-2 Export destination of Chinas lambda-cyhalothrin, 2010, Kg
Table 4.2.1.4-3 Exporters of lambda-cyhalothrin in China, 2010, Kg
Table 4.2.1.4-4 Market volume and value, consumption structure by formulation
types in China, 2008-2010
Table 4.2.2.1-1 Regional distribution of bifenthrin technical registrations in
China, by May 2011
Table 4.2.2.1-2 Registration situation of single formulations of bifenthrin in
China, by May 2011
Table 4.2.2.1-3 Registration situation of mixed formulations of bifenthrin in
China, by May 2011
Table 4.2.2.2-1 Basic information of bifenthrin technical producers in China, as
of May 2011
Table 4.2.2.2-2 Capacity and output of bifenthrin technical producers in China,
as of May 2011
Table 4.2.2.4-1 Apparent consumption of bifenthrin in China, converted to 100%
AI, tonne, 2008-2010
Table 4.2.2.4-2 Export situation of bifenthrin in China, 2010, tonne
Table 4.2.2.4-3 Export volume of bifenthrin in China, 2010, Kg
Table 4.2.2.4-4 Domestic exporter of bifenthrin, 2010, Kg
Table 4.2.2.4-5 Market volume and value of bifenthrin by formulation types in
China, 2008-2010
Table 4.2.3.1-1 Regional distribution of alpha-cypermethrin technical
registrations in China, by May 2011
Table 4.2.3.1-2 Registration situation of single formulations of alpha-cypermethrin
in China, by May 2011
Table 4.2.3.2-1 Basic information of alpha-cypermethrin technical producers in
China, as of May 2011
Table 4.2.3.4-1 Apparent consumption of alpha-cypermethrin calculated by 100% AI
in China, tonne, 2008-2010
Table 4.2.3.4-2 Market volume and value of alpha-cypermethrin by formulation
types in China, 2008-2010
Table 4.2.4.1-1 Regional distribution of beta-cyfluthrin technical registrations
in China, by May 2011
Table 4.2.4.1-2 Registration situation of single formulations of beta-cyfluthrin
in China, by May 2011
Table 4.2.4.2-1 Basic information of beta-cyfluthrin technical producers in
China, as of May 2011
Table 4.2.4.2-2 Capacity and output of beta-cyfluthrin technical producers in
China, as of May 2011
Table 4.2.4.4-1 Apparent consumption of beta-cyfluthrin by 100% AI in China,
tonne, 2008-2010
Table 4.2.4.4-2 Market volume and value of beta-cyfluthrin formulations in
China, 2008-2010
Table 4.2.5.1-1 Regional distribution of deltamethrin technical registered in
China, by May 2011
Table 4.2.5.2-1 Basic information of deltamethrin technical producers in China,
as of May 2011
Table 4.2.5.2-2 Capacity and output of technical producers in China, as of May
2011, Capacity: t/a, Output: t
Table 4.2.5.4-1 Apparent consumption of deltamethrin in China, converted to 100%
AI, tonne, 2008-2011
Table 4.2.5.4-2 Market volume and value of deltamethrin by formulations in
China, 2008-2010
Table 4.2.6.1-1 Regional distribution of cypermethrin technical registrations in
China, by May 2011
Table 4.2.6.1-2 Registration situation of single formulations of cypermethrin in
China, by May 2011
Table 4.2.6.2-1 Basic information of cypermethrin technical producers in China,
as of May 2011
Table 4.2.6.2-2 Capacity and output of cypermethrin technical producers in
China, as of May 2011, Capacity: t/a, Output: t
Table 4.2.6.4-1 Apparent consumption of cypermethrin in China, converted to 100%
AI, tonne, 2008-2011
Table 4.2.6.4-2 Monthly export situation of cypermethrin in China, 2010
Table 4.2.6.4-3 Monthly export situation of cypermethrin in China, 2009
Table 4.2.6.4-4 Export destination of Chinas cypermethrin, 2010, Kg
Table 4.2.6.4-5 Export destination of Chinas cypermethrin, 2009, Kg
Table 4.2.6.4-6 Exporters of cypermethrin in China, 2010, Kg
Table 4.2.6.4-7 Exporters of cypermethrin in China, 2009, Kg
Table 4.2.6.4-8 Market volume and value of cypermethrin by formulation types in
China, 2008-2010
Table 4.2.7.1-1 Regional distribution of fenpropathrin technical registrations
in China, by May 2011
Table 4.2.7.1-2 Registration situation of single formulations of fenpropathrin
in China, by May 2011
Table 4.2.7.2-1 Basic information of fenpropathrin technical producers in China,
as of May 2011
Table 4.2.7.2-2 Capacity and output of fenpropathrin technical producers in
China, as of May 2011, Capacity: t/a, Output: t
Table 4.2.7.4-1 Apparent consumption of fenpropathrin in China, converted to
100% AI, tonne, 2008-2011
Table 4.2.7.4-2 Market volume and value of fenpropathrin by formulation types in
China, 2008-2010
Table 4.2.8.1-1 Regional distribution of fenvalerate technical registrations in
China, by May 2011
Table 4.2.8.1-2 Registration situation of single formulations of fenvalerate in
China, by May 2011
Table 4.2.8.2-1 Basic information of fenvalerate technical producers in China,
as of May 2011
Table 4.2.8.2-2 Capacity and output of fenvalerate technical producers in China,
as of May 2011, Capacity: t/a, Output: t
Table 4.2.8.3-1 Ex-work price of fenvalerate in China, 2007- May 2011
Table 4.2.8.4-1 Apparent consumption of fenvalerate in China, converted to 100%
AI, tonne, 2008-2010
Table 4.2.8.4-2 Monthly export situation of fenvalerate in China, 2010
Table 4.2.8.4-3 Monthly export situation of fenvalerate in China, 2009
Table 4.2.8.4-4 Export destination of fenvalerate in China, 2010, Kg
Table 4.2.8.4-5 Export destination of fenvalerate in China, 2009, Kg
Table 4.2.8.4-6 Exporter of fenvalerate in China, 2010, Kg
Table 4.2.8.4-7 Exporter of fenvalerate in China, 2009, Kg
Table 4.2.8.4-8 Market volume and value of fenvalerate formulations in China,
2008-2010
Table 4.2.9.1-1 Regional distribution of esfenvalerate technical registrations
in China, by May 2011
Table 4.2.9.1-2 Registration situation of single formulations of esfenvalerate
in China, by May 2011
Table 4.2.9.2-1 Basic information of esfenvalerate technical producers in China,
as of May 2011
Table 4.2.9.2-2 Capacity and output of esfenvalerate technical producers in
China, as of May 2011, Capacity: t/a, Output: t
Table 4.2.9.4-1 Apparent consumption of esfenvalerate in China, converted to
100% AI, tonne, 2008-2010
Table 4.2.9.4-2 Market volume and value of esfenvalerate by formulation types in
China, 2008-2010
Table 4.2.10.1-1 Regional distribution of cyfluthrin technical registrations in
China, by May 2011
Table 4.2.10.1-2 Registration situation of single formulations of cyfluthrin in
China, by May 2011
Table 4.2.10.2-1 Basic information of cyfluthrin technical producers in China,
as of May 2011
Table 4.2.10.2-2 Capacity and output of cyfluthrin technical producers in China,
as of May 2011, Capacity: t/a, Output: t
Table 4.2.10.4-1 Apparent consumption of cyfluthrin in China, converted to 100%
AI, tonne, 2008-2011
Table 4.2.10.4-2 Market volume and value of cyfluthrin by formulation types in
China, 2008-2010
Table 4.2.11.1-1 Regional distribution of permethrin technical registrations in
China, by May 2011
Table 4.2.11.1-2 Registration situation of single formulations of permethrin in
China, by May 2011
Table 4.2.11.2-1 Basic information of permethrin technical producers in China,
as of May 2011
Table 4.2.11.2-2 Capacity and output of permethrin technical producers in China,
as of May 2011, Capacity: t/a, Output: t
Table 4.2.11.4-1 Apparent consumption of permethrin in China, converted to 100%
AI, tonne
Table 4.2.11.4-2 Monthly export situation of permethrin in China, 2010
Table 4.2.11.4-3 Monthly export situation of permethrin in China, 2009
Table 4.2.11.4-4 Export destination of Chinas cypermethrin, 2010, Kg
Table 4.2.11.4-5 Export destination of Chinas permethrin, 2009, Kg
Table 4.2.11.4-6 Exporter of permethrin in China, 2010, Kg
Table 4.2.11.4-7 Exporter of permethrin in China, 2009, Kg
Table 4.2.11.4-8 Market volume and value of permethrin by formulation types in
China, 2008-2010
Table 4.2.12.1-1 Regional distribution of beta-cypermethrin technical
registrations in China, by May 2011
Table 4.2.12.1-2 Registration situation of single formulations of beta-cypermethrin
in China, by May 2011
Table 4.2.12.1-3 Registration situation of mixed formulations of beta-cypermethrin
in China, by May 2011
Table 4.2.12.2-1 Basic information of beta-cypermethrin technical producers in
China, as of May 2011
Table 4.2.12.2-2 Capacity and output of beta-cypermethrin technical producers in
China, as of May 2011
Table 4.2.12.4-1 Apparent consumption of beta-cypermethrin in China, converted
to 100% AI, tonne, 2008-2010
Table 4.2.12.4-2 Monthly export situation of beta-cypermethrin in China, 2010
Table 4.2.12.4-3 Monthly export situation of beta-cypermethrin in China, 2009
Table 4.2.12.4-4 Export destination of beta-cypermethrin in China, 2010, Kg
Table 4.2.12.4-5 Export destination of beta-cypermethrin in China, 2009, Kg
Table 4.2.12.4-6 Exporter of beta-cypermethrin in China, 2010, Kg
Table 4.2.12.4-7 Exporter of beta-cypermethrin in China, 2009, Kg
Table 4.2.12.4-8 Market volume and value of beta-cypermethrin formulations in
China, 2008-2010
Table 4.2.13-1 Active tetramethrin technical producers in China, 2010-2011
Table 4.2.13-2 Apparent consumption of tetramethrin by active ingredient in
China, 2010
Table 4.2.13-3 Active prallethrin technical producers in China, 2010-2011
Table 4.2.13-4 Apparent consumption of prallethrin by active ingredient in
China, 2010
Table 4.2.13-5 Active rich-d-t-prallethrin technical producers in China,
2010-2011
Table 4.2.13-6 Apparent consumption of rich-d-t-prallethrin by active ingredient
in China, 2010
Table 5.1.2-1 Chinas policies for boosting peasants income, 2011
Table 5.2-1 Major administrations and policies on pesticides or pesticide
industry in China, 2011
Table 5.2-2 Admittance threshold raised according to the Notice No.285 [2008] by
the National Development and Reform Commission
Table 5.2-3 Environmental protection policies and environmental cost in
pesticide industry in China, as of May 2011
Table 5.6-1 Technologies to be greatly promoted in China, 2011-2015
Table 6.2-1 Forecast on pyrethroids demand by crops in China, 2011-2015, tonne
Table 8-1 Production situation of major pyrethroids in Jiangsu Yangnong Chemical
Group Co., Ltd., 2010-2011
LIST OF FIGURE
Figure 3.3-1 Global insecticide market by market value, 2010
Figure 3.3-2 Global pyrethroid market by crops, 2010
Figure 3.3-3 Global pyrethroid market by pests, 2010
Figure 3.3-4 Global pyrethroid market by regions, 2010
Figure 3.3-5 Advantages of pyrethroids
Figure 3.4-1 Demand structure of different kinds of insecticides by volume in
China, 2010
Figure 4.1.1.1-1 Production situation of pyrethroids in China, 2008-2010
Figure 4.1.2.1-1 Consumption of pyrethroids by AI in China, by volume & value,
2008-2010
Figure 4.1.2.2.1-1 Consumption volume of pyrethroids by application fields in
China, 2008-2010
Figure 4.1.2.2.1-2 Market share of pyrethroids by application fields in China,
2010
Figure 4.1.2.2.2-1 Consumption structure of pyrethroids by crops in China,
calculated by AI, 2010
Figure 4.1.2.2.2-2 Consumption situation by pyrethroids on cotton in China, 2010
Figure 4.1.2.2.2-3 Consumption situation by pyrethroids on fruits in China, 2010
Figure 4.1.2.2.2-4 Consumption situation by pyrethroids on tea in China, 2010
Figure 4.1.2.2.2-5 Consumption situation by pyrethroids on wheat in China, 2010
Figure 4.1.2.2.2-6 Consumption situation by pyrethroids on vegetable & melons in
China, 2010
Figure 4.1.2.2.3-1 Market share of pyrethroids by volume in China, 2010
Figure 4.1.2.2.3-2 Market share of pyrethroids by value in China, 2010
Figure 4.1.2.2.4-1 Domestic pyrethroids consumption structure in agriculture by
region, 2010
Figure 4.2.1.1-1 Structure (quantity and share) of lambda-cyhalothrin
registrations by formulations types in China, as of May 2011
Figure 4.2.1.2-1 Forecast on lambda-cyhalothrin output in China, converted to
100% AI, 2011-2015
Figure 4.2.1.3-1 Ex-work prices of lambda-cyhalothrin in China, 2007-May 2011
Figure 4.2.1.3-2 Forecast on technical price of lambda-cyhalothrin in China,
converted to 100% AI, 2011-2015
Figure 4.2.1.4-1 Monthly export situation of lambda-cyhalothrin technical in
China, 2010
Figure 4.2.1.4-2 Forecast on export volume of lambda-cyhalothrin in China,
converted to 100% AI, 2011-2015
Figure 4.2.1.4-3 Domestic consumption structure of lambda-cyhalothrin, volume(t)
and share, converted to 100% AI, 2010
Figure 4.2.1.4-4 Forecast on domestic consumption of lambda-cyhalothrin,
converted to 100%, 2011-2015
Figure 4.2.2.1-1 Structure of bifenthrin registrations by formulation types in
China (quantity and share), by May 2011
Figure 4.2.2.2-1 Forecast on output of bifenthrin in China, converted to 100%
AI, 2011-2015
Figure 4.2.2.3-1 Ex-work price of bifenthrin in China, 2007-May 2011
Figure 4.2.2.3-2 Forecast on price of bifenthrin technical in China, 2011-2015
Figure 4.2.2.4-1 Monthly export situation of bifenthrin in China, 2010
Figure 4.2.2.4-2 Forecast on export volume of bifenthrin in China, converted to
100% AI, 2011-2015
Figure 4.2.2.4-3 Domestic consumption structure of bifenthrin, volume(t) and
share, converted to 100% AI, 2010
Figure 4.2.2.4-4 Forecast on domestic consumption of bifenthrin, converted to
100% AI, 2011-2015
Figure 4.2.3.1-1 Structure of alpha-cypermethrin registrations by formulations
in China, quantity and share, by May 2011
Figure 4.2.3.2-1 Capacity and output of alpha-cypermethrin technical producers
in China, as of May 2011
Figure 4.2.3.2-2 Forecast on output of alpha-cypermethrin technical in China,
2011-2015
Figure 4.2.3.3-1 Ex-work price of alpha-cypermethrin in China, 2007-May 2011
Figure 4.2.3.3-2 Forecast on ex-work price of alpha-cypermethrin technical in
China, 2011-2015
Figure 4.2.3.4-1 Domestic consumption structure of alpha-cypermethrin by 100%
AI, volume (t) and share, 2010
Figure 4.2.3.4-2 Forecast on domestic consumption of alpha-cypermethrin
(converted to 100% AI), 2011-2015
Figure 4.2.4.1-1 Structure of beta-cyfluthrin registrations by formulations in
China, quantity and share, by May 2011
Figure 4.2.4.2-1 Forecast on output of beta-cyfluthrin technical in China,
2011-2015
Figure 4.2.4.3-1 Ex-work price of beta-cyfluthrin in China, 2007-May 2011
Figure 4.2.4.3-2 Forecast on ex-work price of beta-cyfluthrin technical in
China, 2011-2015
Figure 4.2.4.4-1 Domestic consumption structure of beta-cyfluthrin converted to
100% AI, volume(t) and share, 2010
Figure 4.2.4.4-2 Forecast on consumption of beta-cyfluthrin in China, converted
to 100% AI, 2011-2015
Figure 4.2.5.1-1 Structure of deltamethrin registrations by formulation types in
China, by May 2011
Figure 4.2.5.1-2 Registration situation of single formulations of deltamethrin
in China, by May 2011
Figure 4.2.5.2-1 Forecast on deltamethrin output in China, converted to 100% AI,
2011-2015
Figure 4.2.5.3-1 Ex-work price of deltamethrin TC in China, 2007- May 2011
Figure 4.2.5.3-2 Forecast on price of deltamethrin 95% TC in China, 2011-2015
Figure 4.2.5.4-1 Domestic consumption structure of deltamethrin, converted to
100% AI, 2010
Figure 4.2.5.4-2 Forecast on domestic consumption of deltamethrin, converted to
100% AI, 2011-2015
Figure 4.2.6.1-1 Structure of cypermethrin registrations by formulation types,
by May 2011
Figure 4.2.6.2-1 Forecast on output of cypermethrin technical in China,
2011-2015
Figure 4.2.6.3-1 Ex-work price of cypermethrin 95% TC in China, 2007- May 2011
Figure 4.2.6.3-2 Forecast on price of cypermethrin 95% technical in China,
2011-2015
Figure 4.2.6.4-1 Forecast on export volume of cypermethrin in China, converted
to 100% AI, 2011-2015
Figure 4.2.6.4-2 Domestic consumption structure of cypermethrin, volume(t) and
share, converted to 100% AI, 2010
Figure 4.2.6.4-3 Forecast on domestic consumption of cypermethrin, converted to
100% AI, 2011-2015
Figure 4.2.7.1-1 Structure of fenpropathrin registrations by formulation types
in China, by May 2011
Figure 4.2.7.2-1 Forecast on production output of fenpropathrin in China,
converted to 100% AI, 2011-2015
Figure 4.2.7.3-1 Ex-work price of fenpropathrin in China, 2007- May 2011
Figure 4.2.7.3-2 Forecast on price of fenpropathrin 92% technical in China,
2011-2015
Figure 4.2.7.4-1 Domestic consumption structure of fenpropathrin, volume(t) and
share, converted to AI 100%, 2010
Figure 4.2.7.4-2 Forecast on domestic consumption of fenpropathrin, converted to
100% AI, 2011-2015
Figure 4.2.8.1-1 Structure of fenvalerate registrations by formulation types in
China, by May 2011
Figure 4.2.8.2-1 Forecast on output of fenvalerate in China, converted to 100%
AI, 2011-2015
Figure 4.2.8.3-1 Forecast on price of fenvalerate 92% technical in China,
2011-2015
Figure 4.2.8.4-1 Domestic consumption structure of fenvalerate,volume(t) and
share, converted to AI 100%, 2010
Figure 4.2.8.4-2 Forecast on domestic consumption of fenvalerate, converted to
100% AI, 2011-2015
Figure 4.2.9.1-1 Structure of esfenvalerate registrations by formulation types
in China, by May 2011
Figure 4.2.9.2-1 Forecast of output of esfenvalerate technical in China,
2011-2015
Figure 4.2.9.3-1 Ex-work price of esfenvalerate in China, 2007-May 2011
Figure 4.2.9.3-2 Forecast on price of 95% esfenvalerate technical in China,
2011-2015
Figure 4.2.9.4-1 Domestic consumption structure of esfenvalerate, converted to
100%, 2010
Figure 4.2.9.4-2 Forecast on domestic consumption of esfenvalerate in China,
converted to 100% AI, 2011-2015
Figure 4.2.10.1-1 Structure of cyfluthrin registrations by formulation types in
China, by May 2011
Figure 4.2.10.3-1 Ex-work price of cyfluthrin in China, 2007- May 2011
Figure 4.2.10.3-2 Forecast on price of cyfluthrin 92% technical in China,
2011-2015
Figure 4.2.10.4-1 Domestic consumption structure of cyfluthrin, volume(t) and
share, converted to 100% AI, 2010
Figure 4.2.10.4-2 Forecast on domestic consumption of cyfluthrin, converted to
100% AI, 2011-2015
Figure 4.2.11.1-1 Structure of permethrin registrations by formulation types in
China, by May 2011
Figure 4.2.11.2-1 Forecast on output of 95% permethrin technical in China,
2011-2015
Figure 4.2.11.3-1 Ex-work price of 95% permethrin technical in China, 2007- May
2011
Figure 4.2.11.3-2 Forecast on price of permethrin 95% technical in China,
2011-2015
Figure 4.2.11.4-1 Domestic consumption structure of permethrin, volume(t) and
share, 2010
Figure 4.2.11.4-2 Forecast on domestic consumption of permethrin, converted to
100% AI, 2011-2015
Figure 4.2.12.1-1 Structure (quantity and share) of beta-cypermethrin
registrations by formulation types in China, by May 2011
Figure 4.2.12.2-1 Forecast on output of beta-cypermethrin technical in China,
2011-2015
Figure 4.2.12.3-1 Ex-work price of beta-cypermethrin in China, 2007-May 2011
Figure 4.2.12.3-2 Forecast on ex-work price of 95% beta-cypermethrin technical
in China, 2011-2015
Figure 4.2.12.4-1 Forecast on export volume of beta-cypermethrin in China,
converted to 100% AI, 2011-2015
Figure 4.2.12.4-2 Domestic consumption structure of beta-cypermethrin, volume(t)
and share, converted to 100%, 2010
Figure 4.2.12.4-3 Forecast on domestic consumption of beta-cypermethrin in
China, converted to 100% AI, 2011-2015
Figure 5.1.1-1 Chinas GDP growth, 2001-2010
Figure 5.1.2-1 Income change of Chinese peasants, 2004-2010
Figure 5.3.2-1 Evaluation of Porters 5 Forces of Chinese pyrethroid industry,
2011
Figure 5.4-1 Distribution channel of pyrethroids in China, 2010
Figure 5.5-1 Output and sales volume of 3,3-diMethyl-4-pentenoic acid
methylester in China, 2003-2010
Figure 5.5-2 Ex-work price of thionyl chloride in China, 2007-May 2011
Figure 5.5-3 Consumption structrue of thionyl chloride by volume in China, 2010
Figure 6.1-1 Forecast on capacity and output of pyrethroids by AI in China,
2011-2015, tonne
Figure 6.2-1 Forecast on demand volume and value of pyrethroids in China,
2011-2015
|
